News
-
-
-
PRESS RELEASE
ReelTime's RI Available on 118 Million iPhones and iPads Now Instantly Across North America - More Capable, More Efficient, and No App Store Required
ReelTime Media launches Reel Intelligence (RI) AI platform on Apple devices, offering breakthrough performance with minimal storage. RI competes with ChatGPT, Claude, Perplexity, Deepseek, and Meta AI -
-
-
-
PRESS RELEASE
Radius Pharmaceuticals Announces Victory in Patent Infringement Case Against Orbicular Pharmaceutical Technologies for Osteoporosis Treatment TYMLOS(R)
Radius Pharmaceuticals and Ipsen Pharma win patent infringement suit against Orbicular Pharmaceutical Technologies for TYMLOS® generic for osteoporosis, upholding five patents validity until 2038 -
-
-